Zobrazeno 1 - 10
of 56
pro vyhledávání: '"Barry Woodhams"'
Publikováno v:
Advances in Hematology, Vol 2014 (2014)
Brain contains large amounts of tissue factor, the major initiator of the coagulation cascade. Neuronal apoptosis after intracerebral haemorrhage (ICH) leads to the shedding of procoagulant phospholipids (PPLs). The aim of this study was to investiga
Externí odkaz:
https://doaj.org/article/e6284fbd79f944e4b270fb7a8f4c745e
Autor:
Giovanna Marchetti, Annalisa Castagna, Barry Woodhams, Marcello Baroni, Francesco Bernardi, Oliviero Olivieri, Nicola Martinelli, Barbara Lunghi, Mirko Pinotti, Filippo Stefanoni
Publikováno v:
Thrombosis Research. 189:140-146
Background High plasma levels of activated Factor VII-Antithrombin complex (FVIIa-AT) have been associated with an increased risk of cardiovascular mortality in patients with stable coronary artery disease (CAD). Objectives To investigate if FVIIa-AT
Autor:
Patrizia Pattini, Andrea Ruzzenente, Nicola Martinelli, Annalisa Castagna, P. Van Dreden, Oliviero Olivieri, Silvia Udali, Simone Conci, Simonetta Friso, Tommaso Campagnaro, Alfredo Guglielmi, Sara Moruzzi, Barry Woodhams, Marcello Baroni, Francesco Bernardi
Publikováno v:
Thrombosis Research. 200:S30-S31
Autor:
Aleksandra Antovic, Margareta Holmström, Katarina Bremme, Elisabet Svenungsson, Mariette Adam, A. Vikerfors, Maria Bruzelius, Barry Woodhams, Giorgia Grosso, Anna Eelde, Anna Ågren
Publikováno v:
Thrombosis Research. 158:168-173
Thrombosis and complement activation are pathogenic features of antiphospholipid syndrome (APS). Their molecular link is Plasma carboxypeptidase-B, also known as thrombin activatable fibrinolysis inhibitor (TAFIa), which plays a dual role: anti-fibri
Autor:
Marcello Baroni, Barry Woodhams, Barbara Lunghi, Filippo Stefanoni, Francesco Bernardi, Jacopo Croce, Domenico Girelli, Federica Tosi, Oliviero Olivieri, Silvia Udali, Nicola Martinelli, Annalisa Castagna
Publikováno v:
Thrombosis and haemostasis. 119(2)
Activated factor VII–anti-thrombin (FVIIa-AT) complex is a potential biomarker of pro-thrombotic diathesis reflecting FVIIa–tissue factor (TF) interaction and has been associated with mortality in patients with coronary artery disease (CAD). Prev
Autor:
Syed A. Ahmad, Xiaoyang Qi, Timofey Sovershaev, Zhengtao Chu, Dusten Unruh, Clayton S. Lewis, B. Ünlü, Vladimir Y. Bogdanov, Patrick Van Dreden, Janusz Rak, Georg F. Weber, Alisa S. Wolberg, Nigel Mackman, Divya Ramchandani, Henri H. Versteeg, Ryan D. Keil, Barry Woodhams, Robert Sturm, Mariette Adam
Publikováno v:
Oncotarget, 7(18), 25264-25275
Oncotarget
Oncotarget
Published version. Source at http://doi.org/10.18632/oncotarget.7955. License CC BY 3.0. Alternatively spliced Tissue Factor (asTF) is a secreted form of Tissue Factor (TF), the trigger of blood coagulation whose expression levels are heightened in s
Autor:
Anders Hamsten, Angela Silveira, Barry Woodhams, Susanna Boquist, A. Carlo, M. Adam, Olga McLeod, Pia Lundman
Publikováno v:
International journal of laboratory hematology. 40(3)
INTRODUCTION Factor VII activation occurs postprandially. A proportion of activated factor VII (VIIa) circulates in complex with antithrombin (VIIaAT). Our primary objective was to assess the effects of postprandial lipemia on circulating VIIaAT, pro
Publikováno v:
Clinical Chemistry and Laboratory Medicine (CCLM). 55
The activation of the extrinsic coagulation pathway occurs after endothelial injury when the tissue factor (TF), a transmembrane protein located outside the vasculature, binds factor VII (FVII) or activated FVII (FVIIa). Once formed, the TF-VIIa comp
Autor:
Barry Woodhams, Sabrina Gavasso, Claudia M. Radu, Elena Campello, P. Zerbinati, Luca Spiezia, Paolo Simioni
Publikováno v:
Thrombosis and Haemostasis. 112:432-437
SummaryFactor V Leiden (FVL) and prothrombin gene mutation G20210A (PTM) are the two most common genetic polymorphisms known to predispose carriers to venous thromboembolism (VTE). A recent study in FVL carriers showed that circulating levels of micr
Autor:
Cristiana Bulato, Elena Campello, Barry Woodhams, Luca Spiezia, Sabrina Gavasso, Fabio Dalla Valle, Daniela Tormene, Claudia M. Radu, Paolo Simioni
SummaryMany subjects carrying inherited thrombophilic defects will never experience venous thromboembolism (VTE) while other individuals developed recurrent VTE with no known additional risk factors. High levels of circulating microparticles (MP) hav
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0212a98cc3c01322fcad3e38cd333f7a
http://hdl.handle.net/11577/3297382
http://hdl.handle.net/11577/3297382